Trial
NCT04540874
A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Healthy
Intervention
BI 894416
Why stopped
due to company decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-16